» Articles » PMID: 38748328

Characterization of the Role of Facebook Groups for Patients Who Use Scalp Cooling Therapy: a Survey Study

Overview
Specialties Critical Care
Oncology
Date 2024 May 15
PMID 38748328
Authors
Affiliations
Soon will be listed here.
Abstract

Since the emergence of scalp cooling therapy (SCT) for the prevention of chemotherapy-induced alopecia (CIA), support groups on social media platforms for interested patients have surfaced. Though there are over 20,000 active members across SCT Facebook groups, little is known about how members use this platform. A 23-question survey was posted in five scalp cooling Facebook groups, reaching 219 women. Results indicated that these Facebook groups play clear roles in providing the following: (1) a supportive community for patients, (2) instructions for SCT use, (3) advice regarding insurance coverage and reimbursement, and (4) recommendations for over-the-counter products for hair loss. Despite reported interest in hair loss products, only 5% of patients sought medical treatment from dermatologists. Due to group-specific access restrictions, private Facebook groups provide patients with a protected platform to learn more about SCT from both those with personal experience and SCT company specialists. Providers may consider recommending these online groups to interested patients during the scalp cooling counseling process. As patients with CIA express a growing interest in over-the-counter hair, eyebrow, and eyelash products, it is important for dermatologists to be aware of where their patients obtain recommendations, and further, if these recommendations have clinical evidence of efficacy.

Citing Articles

A mixed studies systematic review on the health and wellbeing effects, and underlying mechanisms, of online support groups for chronic conditions.

Mills F, Drury J, Hall C, Weston D, Symons C, Amlot R Commun Psychol. 2025; 3(1):40.

PMID: 40089592 DOI: 10.1038/s44271-025-00217-6.


The Psychology Behind the Efficacy of a Buddy System for Enhancing Retention in Dermatological Clinical Trials.

Frasier K, Herrick G, Patel H, Kakarla S, Danial L, Konagalla S Cureus. 2024; 16(11):e72986.

PMID: 39640154 PMC: 11617496. DOI: 10.7759/cureus.72986.

References
1.
Ablon G, Kogan S . A Six-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of a Nutraceutical Supplement for Promoting Hair Growth in Women With Self-Perceived Thinning Hair. J Drugs Dermatol. 2018; 17(5):558-565. View

2.
Donovan J, Shapiro R, Shapiro P, Zupan M, Pierre-Louis M, Hordinsky M . A review of scalp camouflaging agents and prostheses for individuals with hair loss. Dermatol Online J. 2012; 18(8):1. View

3.
Munstedt K, Manthey N, Sachsse S, Vahrson H . Changes in self-concept and body image during alopecia induced cancer chemotherapy. Support Care Cancer. 1997; 5(2):139-43. DOI: 10.1007/BF01262572. View

4.
Cigler T, Isseroff D, Fiederlein B, Schneider S, Chuang E, Vahdat L . Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy. Clin Breast Cancer. 2015; 15(5):332-4. DOI: 10.1016/j.clbc.2015.01.003. View

5.
Nikolaou V, Voudouri D, Tsironis G, Charpidou A, Stamoulis G, Triantafyllopoulou I . Cutaneous toxicities of antineoplastic agents: data from a large cohort of Greek patients. Support Care Cancer. 2019; 27(12):4535-4542. DOI: 10.1007/s00520-019-04751-y. View